Friday, 26 January 2018

EMA panel recommends Merck, Pfizer's diabetes drug

(Reuters) - A European Medicines Agency (EMA) panel on Friday recommended granting marketing approval to a diabetes drug developed by Merck & Co and Pfizer Inc.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)